Biologics: The next generation of analgesic drugs?

Drug Discovery Today

Volumn 17, Issue 15-16, 2012, Pages 875-879

  Chessell, Iain P ^a   Dudley, Amanda ^a   Billinton, Andy ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANALGESIC AGENT; ETANERCEPT; FULRANUMAB; INFLIXIMAB; MEDI578; NAPROXEN; NERVE GROWTH FACTOR; PG110; RGN475; TANEZUMAB; UNCLASSIFIED DRUG;

AMPUTATION STUMP; ANALGESIA; ANGINA PECTORIS; AUTOINFLAMMATORY DISEASE; BACKACHE; CANCER PAIN; CHRONIC PAIN; DIABETIC NEUROPATHY; HEADACHE; HERPES ZOSTER; HUMAN; INFLAMMATORY PAIN; MIGRAINE; MYOFASCIAL PAIN; NECK PAIN; NERVE LIGATION; NEUROPATHIC PAIN; NEUROPATHY; ONCOLOGY; OSTEOARTHRITIS; PAIN; PHANTOM PAIN; POSTHERPETIC NEURALGIA; REVIEW; RHEUMATOID ARTHRITIS; SCIATIC NERVE; SPINAL NERVE; TRIGEMINUS NEURALGIA; TUBERCULOSIS; VISCERAL PAIN;

ANALGESICS; ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL AGENTS; HUMANS; PAIN;

EID: 84864592149     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.03.005     Document Type: Review

References (45)

1. G. Burgess, and D. Williams The discovery and development of analgesics: new mechanisms, new modalities J. Clin. Invest. 120 2010 3753 3759
2. D. Schuster Why drugs fail - a study on side effects in new chemical entities Curr. Pharm. Des. 11 2005 3545 3559 (Pubitemid 41300759)
3. R. Hill NK1 (substance P) receptor antagonists - why are they not analgesic in humans? TIPS 21 2000 244 246 (Pubitemid 30445249)
4. J.R. Sneyd Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction Br. J. Anaesth. 98 2007 672 676
5. O. Gureje Persistent pain and well-being: a World Health Organization study in primary care JAMA 280 1998 147 151 (Pubitemid 28498386)
6. H. Breivik Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment Eur. J. Pain 10 2006 287 333
7. C.J. Phillips Economic burden of chronic pain Expert Rev. Pharmacoecon. Outcomes Res. 6 2006 591 601 (Pubitemid 44741608)
8. A. Gustavsson Socio-economic burden of patients with a diagnosis related to chronic pain - register data of 840,000 Swedish patients Eur. J. Pain 16 2012 289 299
9. L. Pickering Lessons learned in the pharmaceutical industry, 2009 Spectrum: Decision Resources 17 2009 1 32
10. A.L. Daugherty Formulation and delivery issues for monoclonal antibody therapeutics Adv. Drug Del. Rev. 58 2006 686 706 (Pubitemid 44255853)
11. Y. Yu Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target Sci. Transl. Med. 3 2011 84ra44
12. E.B. De Souza Novel therapeutic modalities to address nondrugable protein interaction targets Neuropsychopharmacology 34 2009 142 158
13. J.M. Reichert Antibody-based therapeutics to watch in 2011 mAbs 3 2011 76 79
14. G.R. Lewin, and Y.A. Barde Physiology of the neurotrophins Annu. Rev. Neurosci. 19 1996 289 317 (Pubitemid 26080831)
15. S. Pezet, and S.B. McMahon Neurotrophins: mediators and modulators of pain Annu. Rev. Neurosci. 29 2006 507 538 (Pubitemid 44476854)
16. F.F. Hefti Novel class of pain drugs based on antagonism of NGF Trends Pharmacol. Sci. 27 2006 85 91 (Pubitemid 43184029)
17. B.G. Petty The effect of systemically administered recombinant human nerve growth factor in healthy human subjects Ann. Neurol. 36 1994 244 246 (Pubitemid 24239246)
18. M.A. Sevcik Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization Pain 115 2005 128 141
19. G.S. Kryger Nerve growth factor inhibition prevents traumatic neuroma formation in the rat J. Hand Surg. Am. 26 2001 635 644 (Pubitemid 32661383)
20. S.I. Jaggar Inflammation of the rat urinary bladder is associated with a referred thermal hyperalgesia which is nerve growth factor dependent Br. J. Anaesth. 83 1999 442 448 (Pubitemid 29412699)
21. N. Lane Tanezumab for the treatment of pain from osteoarthritis of the knee N. Engl. J. Med. 363 2010 1521 1531
22. N. Katz Efficacy and safety of tanezumab in the treatment of chronic low back pain Pain 152 2011 2248 2258
23. R. Evans Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis J. Urol. 185 2011 1716 1721
24. I.P. Chessell Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain Pain 114 2005 386 396 (Pubitemid 40385877)
25. J.A. DeLeo Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model J. Interferon Cytokine Res. 16 1996 695 700
26. P.G. Murphy Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes neuropeptides associated with chronic nerve constriction in mice Eur. J. Neurosci. 11 1999 2243 2253 (Pubitemid 29292318)
27. D. Brenn Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain Arthritis Rheum. 56 2007 351 359 (Pubitemid 46106209)
28. M.S. Ramer Spinal nerve lesion induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice Pain 78 1998 115 121 (Pubitemid 28517949)
29. N. Kiguchi The cirtical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice Eur. J. Pharmacol. 592 2008 87 92
30. W. Ma, and R. Quirion Increased calcitonin gene-related peptide in neuroma and invading macrophages is involved in the upregulation of interleukin-6 and thermal hyperalgesia in a rat model of mononeuropathy J. Neurochem. 98 2006 180 192 (Pubitemid 43882943)
31. R. Kiefer The role of macrophages in immune-mediated damage to the peripheral nervous system Prog. Neurobiol. 64 2001 109 127 (Pubitemid 32195409)
32. J.S. Smolen Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial Lancet 371 2008 987 997 (Pubitemid 351392039)
33. Y. Yazici Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study Ann. Rheum. Dis. 71 2012 198 205
34. M. Vardanyan Reversal of pancreatitis-induced pain by an orally available, small molecule interleukin-6 receptor antagonist Pain 151 2010 257 265
35. J.J. Cush Unusual toxicities with TNF inhibition: heart failure and drug-induced lupus Clin. Exp. Rheumatol. 22 Suppl. 35 2004 141 147
36. T.M. Cunha A cascade of cytokines mediates mechanical inflammatory hypernociception in mice Proc. Natl. Acad. Sci. U.S.A. 102 2005 1755 1760 (Pubitemid 40209240)
37. C.J. Woolf Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha Br. J. Pharmacol. 121 1997 417 424 (Pubitemid 27226293)
38. H.G. Schaible The role of proinflammatory cytokines in the generation and maintenance of joint pain Ann. N. Y. Acad. Sci. 1193 2010 60 69
39. C. Sommer Etanercept reduces hyperalgesia in experimental painful neuropathy J. Peripher. Nerv. Syst. 6 2001 67 72 (Pubitemid 32606886)
40. L.W. Moreland Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein N. Engl. J. Med. 337 1997 141 147 (Pubitemid 27306284)
41. R.N. Maini Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum. 41 1998 1552 1563 (Pubitemid 28459913)
42. J. Zalevsky Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection J. Immunol. 179 2007 1872 1883
43. Y. Mukai Fast binding kinetics and conserved 3D structure underlie the antagonistic activity of mutant TNF: useful information for designing artificial proteo-antagonists J. Biochem. 146 2009 167 172
44. A. Schmidtko Ziconotide for the treatment of severe pain Lancet 375 2010 1569 1577
45. A. Gupta Antibodies against G-protein coupled receptors: novel uses in screening and drug development Comb. Chem. HTS 11 2008 463 467 (Pubitemid 351969362)